• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者的侵袭性真菌感染:血液学和传染病领域一个可能日益严重的问题。

Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases.

作者信息

Valkovic Toni, Marcelic Lucija, Valkovic Frane

机构信息

Special Hospital Medico, Rijeka, Croatia.

Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.

出版信息

Ther Adv Infect Dis. 2024 Mar 26;11:20499361241238518. doi: 10.1177/20499361241238518. eCollection 2024 Jan-Dec.

DOI:10.1177/20499361241238518
PMID:38545449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10966984/
Abstract

Multiple myeloma is among the most common hematological malignancies and is characterized by a strong susceptibility to infections primarily bacterial and viral and, to a much lesser extent, fungal. There appears to be a slightly increasing frequency of invasive fungal infections. This is attributed to the use of different combinations of newer drugs and patients' exposure to increasing therapeutic lines, and thus to risk factors for invasive fungal infections, especially severe and long-term neutropenia. Novel immunotherapy modalities including bispecific antibodies and chimeric antigen receptor T-cell therapy are being introduced for the treatment of relapsing-refractory forms of the disease. Consequently, in the near future, it can be expected that myeloma patients will exhibit a significantly increased frequency of invasive fungal infections. Therefore, we must carefully monitor all epidemiological trends related to invasive fungal infections in patients with multiple myeloma, both in clinical studies and in real life. This will help us learn to prevent fungal infections, as well as quickly recognize and treat them to reduce their impact on patients' morbidity and mortality. In this review article, we describe in detail the epidemiological characteristics of invasive fungal infections in myeloma patients, the risk factors for these infections, and the treatment and prevention options.

摘要

多发性骨髓瘤是最常见的血液系统恶性肿瘤之一,其特点是对感染具有高度易感性,主要是细菌和病毒感染,真菌感染的程度要小得多。侵袭性真菌感染的频率似乎略有上升。这归因于新型药物的不同组合使用以及患者接受越来越多的治疗疗程,从而导致侵袭性真菌感染的风险因素增加,尤其是严重和长期的中性粒细胞减少。包括双特异性抗体和嵌合抗原受体T细胞疗法在内的新型免疫治疗方式正在被引入用于治疗复发难治性骨髓瘤。因此,在不久的将来,可以预期骨髓瘤患者侵袭性真菌感染的频率将显著增加。因此,我们必须在临床研究和现实生活中仔细监测多发性骨髓瘤患者与侵袭性真菌感染相关的所有流行病学趋势。这将有助于我们学会预防真菌感染,并迅速识别和治疗它们,以减少其对患者发病率和死亡率的影响。在这篇综述文章中,我们详细描述了骨髓瘤患者侵袭性真菌感染的流行病学特征、这些感染的风险因素以及治疗和预防方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa5d/10966984/33557b2b8b5f/10.1177_20499361241238518-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa5d/10966984/33557b2b8b5f/10.1177_20499361241238518-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa5d/10966984/33557b2b8b5f/10.1177_20499361241238518-fig1.jpg

相似文献

1
Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases.多发性骨髓瘤患者的侵袭性真菌感染:血液学和传染病领域一个可能日益严重的问题。
Ther Adv Infect Dis. 2024 Mar 26;11:20499361241238518. doi: 10.1177/20499361241238518. eCollection 2024 Jan-Dec.
2
Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).血液系统恶性肿瘤和实体瘤患者侵袭性真菌感染的预防——德国血液学和肿瘤学会(DGHO)传染病工作组(AGIHO)指南
Ann Hematol. 2003 Oct;82 Suppl 2:S186-200. doi: 10.1007/s00277-003-0773-3. Epub 2003 Sep 11.
3
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.嵌合抗原受体 T 细胞和双特异性抗体治疗多发性骨髓瘤期间感染预防的建议。
Br J Haematol. 2023 Dec;203(5):736-746. doi: 10.1111/bjh.18909. Epub 2023 Jun 7.
4
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?CMV 与淋巴增生性恶性肿瘤自体干细胞移植后侵袭性真菌感染的关系:机会性伙伴关系还是因果关系?
Int J Mol Sci. 2019 Mar 19;20(6):1373. doi: 10.3390/ijms20061373.
5
Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?血液系统恶性肿瘤中性粒细胞减少患者的抗真菌预防:真的有益吗?
Chemotherapy. 1999 May-Jun;45(3):224-32. doi: 10.1159/000007187.
6
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.免疫疗法在靶向多发性骨髓瘤骨髓微环境中的作用:一种不断发展的治疗策略。
Pharmacotherapy. 2017 Jan;37(1):129-143. doi: 10.1002/phar.1871. Epub 2017 Jan 6.
7
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).癌症患者侵袭性真菌感染的治疗——德国血液与肿瘤学会感染病工作组(AGIHO)2019 年修订建议。
Mycoses. 2020 Jul;63(7):653-682. doi: 10.1111/myc.13082. Epub 2020 May 12.
8
Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study.重症监护病房患者侵袭性真菌感染的泛印度临床登记:一项多中心前瞻性研究方案
JMIR Res Protoc. 2024 Feb 16;13:e54672. doi: 10.2196/54672.
9
[Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors].[血液系统恶性肿瘤患者的侵袭性霉菌感染:环境因素的影响]
Mikrobiyol Bul. 2022 Apr;56(2):315-325. doi: 10.5578/mb.20229810.
10
Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies.铁及铁过载在血液系统恶性肿瘤患者侵袭性真菌感染发病机制中的作用
J Clin Med. 2022 Jul 30;11(15):4457. doi: 10.3390/jcm11154457.

引用本文的文献

1
Invasive Mucormycosis in a Chronic Lymphocytic Leukemia Patient on Zanubrutinib: A Case Report.一例接受泽布替尼治疗的慢性淋巴细胞白血病患者发生侵袭性毛霉病:病例报告
Infect Drug Resist. 2025 Jul 4;18:3281-3287. doi: 10.2147/IDR.S526660. eCollection 2025.
2
Update on invasive fungal infections: emerging trends in the incidence of fungal infections in immunosuppressed patients and associated conditions.侵袭性真菌感染的最新情况:免疫抑制患者真菌感染发病率的新趋势及相关病症
Ther Adv Infect Dis. 2024 Sep 27;11:20499361241282835. doi: 10.1177/20499361241282835. eCollection 2024 Jan-Dec.
3
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.

本文引用的文献

1
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?基于放射学的高危血液病患者肺部真菌感染诊断:我们是否在取得进展?
Curr Opin Infect Dis. 2023 Aug 1;36(4):250-256. doi: 10.1097/QCO.0000000000000937. Epub 2023 Jun 9.
2
Epidemiology and Outcomes of Non-albicans Candida Bloodstream Infections in Transplant Recipients and Cancer Patients.移植受者和癌症患者中非白色念珠菌血流感染的流行病学和结局。
Mycopathologia. 2023 Dec;188(6):863-871. doi: 10.1007/s11046-023-00765-7. Epub 2023 Jun 26.
3
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
免疫球蛋白替代疗法:对多发性骨髓瘤管理的见解
Cancers (Basel). 2024 Sep 18;16(18):3190. doi: 10.3390/cancers16183190.
血液恶性肿瘤患者侵袭性真菌病的一级预防:德国血液学和肿瘤内科学会(DGHO)传染病工作组(AGIHO)的建议 2022 年更新版。
J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143.
4
Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study.血液恶性肿瘤患者的突破性侵袭性真菌感染:一项全国性、前瞻性、多中心研究。
J Infect. 2023 Jul;87(1):46-53. doi: 10.1016/j.jinf.2023.05.005. Epub 2023 May 16.
5
Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis.高危患者侵袭性肺曲霉病支气管肺泡灌洗液聚合酶链反应:诊断性荟萃分析。
BMC Pulm Med. 2023 Feb 7;23(1):58. doi: 10.1186/s12890-023-02343-5.
6
Prolonged duration of lymphocyte deficiency, high-grade CRS, and ventilation are linked to fungal breakthrough in patients with hematologic malignancies 60 days after CAR-T infusion: A single center case-control study.淋巴细胞缺乏持续时间长、高等级 CRS 和通气与 CAR-T 输注后 60 天血液恶性肿瘤患者的真菌突破有关:一项单中心病例对照研究。
J Infect Public Health. 2022 Dec;15(12):1521-1530. doi: 10.1016/j.jiph.2022.11.017. Epub 2022 Nov 22.
7
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.血液学中Magnusiomyces(Saprochaete)感染的临床特征及预后因素。SEIFEM/Fungiscope多中心研究。
Mycoses. 2023 Jan;66(1):35-46. doi: 10.1111/myc.13524. Epub 2022 Sep 19.
8
Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies.铁及铁过载在血液系统恶性肿瘤患者侵袭性真菌感染发病机制中的作用
J Clin Med. 2022 Jul 30;11(15):4457. doi: 10.3390/jcm11154457.
9
Teclistamab in Relapsed or Refractory Multiple Myeloma.特卡昔单抗治疗复发或难治性多发性骨髓瘤。
N Engl J Med. 2022 Aug 11;387(6):495-505. doi: 10.1056/NEJMoa2203478. Epub 2022 Jun 5.
10
Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.来自科威特一家三级保健医院免疫功能低下患者的耳念珠菌分离株的分子特征显示 FKS1 中的一种新突变导致对棘白菌素类药物的敏感性降低。
Mycoses. 2022 Mar;65(3):331-343. doi: 10.1111/myc.13419. Epub 2022 Jan 3.